| 产品名称 |
点击数 |
| Anti-Human CD30/TNFRSF8 Recombinant Antibody, PE|抗人CD30/TNFRSF8重组抗体,PE标记(靶标:肿瘤坏死因子受体超家族成员8/CD30) |
541 |
| Anti-Human CD30/TNFRSF8 Recombinant Antibody , PE|抗人CD30/TNFRSF8重组抗体,PE标记(靶标:肿瘤坏死因子受体超家族成员8/CD30) |
263 |
| Anti-Human CD30/TNFRSF8 Recombinant Antibody, PE|抗人CD30/TNFRSF8重组抗体,PE标记(靶标:肿瘤坏死因子受体超家族成员8/CD30) |
326 |
| Anti-Human CD30/TNFRSF8 Recombinant Antibody , PE|抗人CD30/TNFRSF8重组抗体,PE标记(靶标:肿瘤坏死因子受体超家族成员8/CD30) |
299 |
| Anti-Human A2AR/ADORA2A Recombinant Antibody , PE|抗人A2AR/ADORA2A重组抗体,PE标记(靶标:腺苷A2a受体) |
234 |
| Anti-Human CTGF/CCN2 Recombinant Antibody , PE|抗人CTGF/CCN2重组抗体,PE标记(靶标:结缔组织生长因子/CCN2) |
425 |
| Anti-Human EPHA2 Recombinant Antibody , PE|抗人EPHA2重组抗体,PE标记(靶标:肝配蛋白A型受体2) |
231 |
| Anti-Human EPHA3 Recombinant Antibody , PE|抗人EPHA3重组抗体,PE标记(靶标:肝配蛋白A型受体3) |
489 |
| Anti-Human IL12A/IL-12 p35/NKSF1 Recombinant Antibody , PE|抗人IL12A/IL-12 p35/NKSF1重组抗体,PE标记(靶标:白细胞介素12A/IL-12 p35亚基/NKSF1) |
420 |
| Anti-Human IL12B/IL-12 p40/NKSF2 Recombinant Antibody , PE|抗人IL12B/IL-12 p40/NKSF2重组抗体,PE标记(靶标:白细胞介素12B/IL-12 p40亚基/NKSF2) |
529 |
| Anti-Human CD154/CD40LG/TNFSF5 Recombinant Antibody , PE|抗人CD154/CD40LG/TNFSF5重组抗体,PE标记(靶标:CD40配体/CD154/TNFSF5) |
418 |
| Anti-Human CD154/CD40LG/TNFSF5 Recombinant Antibody, PE|抗人CD154/CD40LG/TNFSF5重组抗体,PE标记(靶标:CD40配体/CD154/TNFSF5) |
386 |
| Anti-Mouse CD154/CD40L/TNFSF5 Recombinant Antibody, PE|抗小鼠CD154/CD40L/TNFSF5重组抗体,PE标记(靶标:CD40配体/CD154/TNFSF5) |
409 |
| Anti-Human CD6 Recombinant Antibody, PE|抗人CD6重组抗体,PE标记(靶标:CD6分子) |
424 |
| Anti-Human AXL/UFO Recombinant Antibody , PE|抗人AXL/UFO重组抗体,PE标记(靶标:AXL受体酪氨酸激酶/UFO) |
255 |
| Anti-Human AXL/UFO Recombinant Antibody , PE|抗人AXL/UFO重组抗体,PE标记(靶标:AXL受体酪氨酸激酶/UFO) |
308 |
| Anti-Human CD52 Recombinant Antibody , PE|抗人CD52重组抗体,PE标记(靶标:CD52分子) |
424 |
| Anti-Human CD52 Recombinant Antibody , PE|抗人CD52重组抗体,PE标记(靶标:CD52分子) |
353 |
| Anti-Human IL4 receptor complex Recombinant Antibody, PE|抗人IL-4受体复合物重组抗体,PE标记(靶标:白细胞介素4受体) |
341 |
| Anti-Human CD132/IL2RG Recombinant Antibody, PE|抗人CD132/IL2RG重组抗体,PE标记(靶标:白细胞介素2受体γ亚基/CD132) |
494 |